Peter Feinberg - Jul 29, 2021 Form 3/A - Amendment Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Peter Feinberg
Stock symbol
IMRX
Transactions as of
Jul 29, 2021
Transactions value $
$0
Form type
3/A - Amendment
Date filed
9/13/2021, 04:31 PM
Date Of Original Report
Jul 29, 2021
Next filing
Aug 4, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IMRX Class A Common Stock 124K Jul 29, 2021 See footnote F1
holding IMRX Class A Common Stock 224K Jul 29, 2021 See footnote F2, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IMRX Stock Option Jul 29, 2021 Class A Common Stock 111K $3.01 Direct F3
holding IMRX Series A Preferred Stock Jul 29, 2021 Class A Common Stock 103K See footnote F1, F4
holding IMRX Series A Preferred Stock Jul 29, 2021 Class A Common Stock 92.5K See footnote F2, F4
holding IMRX Series A Preferred Stock Jul 29, 2021 Class A Common Stock 51.5K See footnote F4, F5
holding IMRX Series B Preferred Stock Jul 29, 2021 Class A Common Stock 30.6K See footnote F1, F4
holding IMRX Series B Preferred Stock Jul 29, 2021 Class A Common Stock 30.6K See footnote F2, F4
holding IMRX Series B Preferred Stock Jul 29, 2021 Class A Common Stock 30.6K See footnote F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Feinberg is a General Partner of PF Associates L.P.
F2 Mr. Feinberg is a General Partner of PEF LLC.
F3 The option vests and becomes exercisable as to 25% of the underlying shares on December 16, 2020 and then in equal monthly installments over the subsequent three years, subject to Mr. Feinberg's continued service to the Issuer's board of directors through each applicable vesting date.
F4 Each share of the Issuer's preferred stock is convertible on a one-for-one basis into shares of the Issuer's Class A common stock in certain circumstances and has no expiration date. The preferred stock will automatically convert into Class A common stock immediately prior to the closing of the Issuer's initial public offering.
F5 Mr. Feinberg is a General Partner of S4K Investments LLC.
F6 This amount includes 47 shares of Class A Common Stock PEF LLC holds through Boxcar PMJ, LLC that was inadvertently omitted from the reporting person's original Form 3 and one subsequent Form 4 filing.

Remarks:

Exhibit 24.1 - Power of Attorney for Peter Feinberg